Invesco Ltd. 13D and 13G filings for Veracyte, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2023-02-09 7:18 pm Sale | 2023-02-14 | 13G | Veracyte, Inc. VCYT | Invesco Ltd. IVZ | 313,974 0.400% | -3,800,057![]() (-92.37%) | Filing |
2022-02-10 11:32 am Purchase | 2022-02-09 | 13G | Veracyte, Inc. VCYT | Invesco Ltd. IVZ | 4,114,031 5.800% | 546,446![]() (+15.32%) | Filing |
2021-02-12 3:34 pm Purchase | 2021-02-12 | 13G | Veracyte, Inc. VCYT | Invesco Ltd. IVZ | 3,567,585 6.200% | 229,696![]() (+6.88%) | Filing |